Form 4: Colgate-Palmolive CGO Awarded Significant Equity

Colgate-Palmolive's Chief Growth Officer, John Hazlin, received a substantial equity award comprising restricted stock units and stock options.

Summary

• John Hazlin, Chief Growth Officer of Colgate-Palmolive Co. (CL), was granted equity awards on September 11, 2025.
• The awards include 4,045 shares of Common Stock as Restricted Stock Units (RSUs) and 28,007 Stock Options.
• The RSUs were granted at a price of $0.0000 and will vest in equal 1/3 installments on the first, second, and third anniversaries of the grant date.
• The Stock Options were granted at an exercise price of $84.06 and will become exercisable in equal annual installments over three years, starting on the first anniversary of the September 11, 2025 grant date.
• The Stock Options have an expiration date of September 11, 2033.
• Following these transactions, John Hazlin directly beneficially owns 18,455 shares of Common Stock and 28,007 Stock Options.
• Additionally, 5,382 shares of Common Stock are indirectly beneficially owned by Hazlin through the Issuer's 401(k) Plan Trustee.

Sentiment

Score: 7

Explanation: The filing reports a routine executive compensation grant, which is a positive for executive retention and alignment with shareholder interests, but does not indicate any new operational or financial performance. It's a standard disclosure.

Positives

• The equity awards align the Chief Growth Officer's interests with long-term shareholder value, as the value of the awards is tied to the company's stock performance.
• The grant of restricted stock units and stock options is a common and effective method of executive compensation, incentivizing performance and retention.

Future Outlook

The future outlook for these awards involves the vesting of restricted stock units in equal annual installments over three years and the exercisability of stock options also in equal annual installments over three years, both commencing on the first anniversary of the September 11, 2025 grant date. The value realized by the executive will depend on Colgate-Palmolive's stock performance over these periods.

Industry Context

Equity-based compensation, such as restricted stock units and stock options, is a standard component of executive remuneration packages across the consumer goods industry. This practice is designed to align the interests of executives with those of shareholders by tying a significant portion of their compensation to the company's long-term stock performance and strategic growth.

Comparison to Industry Standards

• Equity-based compensation, including restricted stock units and stock options, is a standard practice for executive remuneration in large consumer goods companies like Procter & Gamble, Unilever, and Kimberly-Clark.
• The specific size of the award for a Chief Growth Officer would typically be benchmarked against peer companies of similar market capitalization and industry, aiming to align executive incentives with long-term shareholder value creation.

Stakeholder Impact

• Shareholders: The equity awards align the Chief Growth Officer's incentives with shareholder value creation, potentially leading to better long-term performance.
• Employees: No direct impact on general employees is indicated by this filing, though executive compensation practices can influence overall company culture and morale.

Next Steps

• The restricted stock units will vest in three equal annual installments starting September 11, 2026.
• The stock options will become exercisable in three equal annual installments starting September 11, 2026.

Key Dates

Keywords

Colgate-Palmolive, CL, John Hazlin, Form 4, Insider Transaction, Equity Award, Restricted Stock Unit, Stock Option, Executive Compensation, Corporate Governance